Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06765291 · ClinicalTrials.gov registry record · NA

Behavioral Intervention for Youth to Promote Vaping Cessation

A NA study of Nicotine Dependence and Vaping, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT06765291 is a NA study of Nicotine Dependence and Vaping that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 400 participants, above the 181-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (121% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06765291, a NA study of Nicotine Dependence and Vaping, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

This study will test the hypothesis that the QuitVaping (QV) intervention and additional texting support will improve nicotine abstinence rates in adolescents as compared to Enhanced Usual Care (EUC: education about nicotine, vaping and addiction, advice to quit vaping, referral to TIQ texting support). Approximately 400 adolescents will be randomly assigned to one of two arms (1) QuitVaping intervention plus texting support to quit vaping and (2) EUC only.

Interventions

  • BEHAVIORAL QuitVaping
  • BEHAVIORAL This is Quitting (TIQ)

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital, Center for Addiction Medicine, 101 Merrimac Street, Suite 320, Boston, MA 02114 - Boston

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2025-06-18
Est. Completion 2028-09-27
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT06765291

The ClinicalTrials.gov registry entry for NCT06765291 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 181-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (121% higher). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Nicotine Dependence appearing as the primary indexed condition, and to 2 interventions - of which QuitVaping is the first listed.

NCT06765291 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06765291 about?

NCT06765291 is a clinical study titled "Behavioral Intervention for Youth to Promote Vaping Cessation". This study will test the hypothesis that the QuitVaping (QV) intervention and additional texting support will improve nicotine abstinence rates in adolescents as compared to Enhanced Usual Care (EUC: education about nicotine, vaping and addiction, advice to quit vaping, referral to TIQ texting suppo...

What is the current status of trial NCT06765291?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2025-06-18. Estimated completion is 2028-09-27.

What conditions does trial NCT06765291 study?

This clinical trial studies the following conditions: Nicotine Dependence, Vaping, Vaping Teens.

What interventions are being tested in trial NCT06765291?

The interventions under investigation include: QuitVaping (BEHAVIORAL), This is Quitting (TIQ) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06765291?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06765291 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nicotine Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.